Patent US2266517A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4704355A Expired / Lapsed US ⏱️ 0.0 years remaining

Assay utilizing ATP encapsulated within liposome particles

Assignee: Aberlyn Capital Management LP
•
Filing: 1985-03-27
•
Granted: 1987-11-03
•
Expires: 2005-03-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An assay utilizing receptor or antibody sensitized liposome particles which have ATP encapsulated therein. The ATP is released by lysing the liposomes, and detected by means of luciferin-luciferase reagent and a luminometer. The assay provides a very sensitive process for detecting the presence of analytes such as antigens and DNA probes.

Inventors

  • 👤 David Bernstein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 19:54
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/58; G01N33/585; G01N33/586; C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816; G01N33/53; G01N33/531; G01N33/532; Y; Y10; Y10S; Y10S436/00; Y10S436/827; Y10S436/829

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 109 words
A process for assaying an analyte, said analyte being a member of a specific binding pair selected from the group consisting of ligand and antiligand, wherein said process comprises the steps of: obtaining a first fluid suspected of containing the analyte to be determined, combining the first fluid with a solid support, said support having been sensitized with receptors that will bind the analyte to be determined, contacting the support with a second fluid comprising ATP encapsulated within the walls of liposomes, said liposomes having bonded thereto a compound, wherein said compound is ligand, ligand analog, or antiligand, and testing for the presence of ATP associated with the support.
Claim 2
Dependent Claim 109 words
A process for assaying an analyte, said analyte being a member of a specific binding pair selected from the group consisting of ligand and antiligand, wherein said process comprises the steps of: obtaining a first fluid suspected of containing the analyte to be determined, combining the first fluid with a solid support, said support having been sensitized with receptors that will bind the analyte to be determined, contacting the support with a second fluid comprising ATP encapsulated within the walls of liposomes, said liposomes having bonded thereto a compound, wherein said compound is ligand, ligand analog, or antiligand, and testing for the presence of ATP associated with the support.
Claim 3
Dependent Claim 58 words
The process of claim 1, wherein the step of testing for the presence of ATP includes the steps of: contacting the solid support and bound immunological particles thereon with a reagent capable of releasing the ATP from the liposomes, mixing the released ATP with luciferin-luciferase reagent, and determining the amount of released ATP by means of a luminometer.
Claim 4
Dependent Claim 21 words
The process of claim 1, further including the steps of washing the substrate before and after contact with the second fluid.
Claim 5
Dependent Claim 12 words
The process of claim 1, wherein the solid support is a bead.
Claim 6
Dependent Claim 12 words
The process of claim 1, wherein the solid support is a strip.
Claim 7
Dependent Claim 12 words
The process of claim 1, wherein the solid support is a membrane.
Claim 8
Dependent Claim 12 words
The process of claim 1, wherein said analyte is a DNA probe.
Claim 9
Dependent Claim 18 words
The process of claim 1, wherein the compound bonded to the liposome is capable of binding the analyte.
Claim 10
Dependent Claim 20 words
The process of claim 8, wherein upon testing, the presence of analyte is indicated by a significant presence of ATP.
Claim 11
Dependent Claim 30 words
The process of claim 8 further including the step of prior to said testing for ATP, filtering said second fluid to remove liposomes which do not bind to said analyte.
Claim 12
Dependent Claim 23 words
The process of claim 1, wherein the compound bonded to the liposome is capable of binding to the receptors on the solid support.
Claim 13
Dependent Claim 20 words
The process of claim 11, wherein upon testing, the presence of analyte is indicated by the relative absence of ATP.
Claim 14
Dependent Claim 30 words
The process of claim 11, further including the step of prior to said testing for ATP, filtering said second fluid to remove liposomes which do not bind to the receptors.
Claim 15
Dependent Claim 142 words
A process for determining the presence of hybridized DNA comprising the steps of: providing a first fluid comprising at least one DNA probe, said DNA probe having bonded thereto a first compound, wherein said first compound is ligand, ligand analog, or antiligand, combining said first fluid with a second fluid suspected of containing complementary DNA, said complementary DNA is complementary to said at least one DNA probe. immobilizing, on a support, any hybridized DNA formed from combining said first fluid with said second fluid, contacting said support and said any immobilized hybridized DNA with a third fluid comprising ATP encapsulated within the walls of lipsomes, said liposomes having bonded thereto a second compound, said second compound is a ligand, ligand analog, or antiligand, which is capable of binding said first compound, and testing for the presence of ATP associated with the support.
Claim 16
Dependent Claim 142 words
A process for determining the presence of hybridized DNA comprising the steps of: providing a first fluid comprising at least one DNA probe, said DNA probe having bonded thereto a first compound, wherein said first compound is ligand, ligand analog, or antiligand, combining said first fluid with a second fluid suspected of containing complementary DNA, said complementary DNA is complementary to said at least one DNA probe. immobilizing, on a support, any hybridized DNA formed from combining said first fluid with said second fluid, contacting said support and said any immobilized hybridized DNA with a third fluid comprising ATP encapsulated within the walls of lipsomes, said liposomes having bonded thereto a second compound, said second compound is a ligand, ligand analog, or antiligand, which is capable of binding said first compound, and testing for the presence of ATP associated with the support.
Claim 17
Dependent Claim 58 words
The process of claim 14, wherein the step of testing for the presence of ATP includes the steps of: contacting the solid support and said any immobilized hybridized DNA with a reagent capable of releasing the ATP from liposomes, mixing the released ATP with luciferin-luciferase reagent, and determining the amount of released ATP by means of a luminometer.
Claim 18
Dependent Claim 15 words
The process of claim 14, wherein said first and second compounds are biotin and avidin.
Claim 19
Dependent Claim 15 words
The process of claim 14, wherein said first and second compounds are fluorescein and antifluorescein.
Claim 20
Dependent Claim 21 words
The process of claim 14, wherein said first and second compounds are a hapten and an antibody specific to said hapten.
Claim 21
Dependent Claim 25 words
The process of claim 14, wherein said first and second compounds are a lectin and a sugar moiety-containing compound which will bind to said lectin.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-11-02 1991-05-04 1991-11-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-11-02 1995-05-04 1995-11-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-11-02 1999-05-04 1999-11-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag